Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00
Go back to Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 4.75 +0.06 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.69 | 52 Week High | $0.40 | |||
| Open | $4.78 | 52 Week Low | $0.40 | |||
| Day High | $4.87 | P/E | N/A | |||
| Day Low | $4.71 | EPS | $0.00 | |||
| Volume | 558,938 | |||||
